Terms: = Breast cancer AND CEACAM5, CEA AND Staging
52 results:
1. Implications of Pretreatment Serum Carcinoembryonic Antigen Levels and Perineural Invasion with staging, Prognosis, and Management in Stage I-III Colon cancer after Surgery: A Retrospective Cohort Study in the SEER Database.
Zhang Q; Wang L; Sun R; Gao J; Liu T
Ann Ital Chir; 2024; 95(2):144-154. PubMed ID: 38684496
[TBL] [Abstract] [Full Text] [Related]
2. FDG-PET/CT for Primary staging and Detection of Recurrence of breast cancer.
Groheux D
Semin Nucl Med; 2022 Sep; 52(5):508-519. PubMed ID: 35636977
[TBL] [Abstract] [Full Text] [Related]
3. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of breast cancer and its Association With Pathological Features and Molecular Types.
Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
[TBL] [Abstract] [Full Text] [Related]
4. Expressiveness of Bone Markers in breast cancer with Bone Metastases.
Zulauf N; Brüggmann D; Groneberg D; Oremek GM
Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
[TBL] [Abstract] [Full Text] [Related]
6. [CA 125 assay in the extension assessment of newly diagnosed breast cancers: why and how?].
Laffont A; Goussot V; Berriolo-Riedinger A; Riedinger JM
Ann Biol Clin (Paris); 2018 Oct; 76(5):553-561. PubMed ID: 30154065
[TBL] [Abstract] [Full Text] [Related]
7. Clinical value of cea for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3.
Maccio G; Goussot V; Berriolo-Riedinger A; Riedinger JM
Ann Biol Clin (Paris); 2017 Aug; 75(4):431-441. PubMed ID: 28751288
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Surgical Resection for Gallbladder cancer with Para-Aortic Lymph Node Metastasis Following Neoadjuvant Chemotherapy with Gemcitabine, Cisplatin, and TS-1].
Nagaoka S; Yamada D; Eguchi H; Noda T; Asaoka T; Wada H; Kawamoto K; Gotoh K; Umeshita K; Doki Y; Mori M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1600-1602. PubMed ID: 28133070
[TBL] [Abstract] [Full Text] [Related]
9. Sclerosing odontogenic carcinoma presenting on the hard palate of a 43-year-old female: a case report.
Wood A; Young F; Morrison J; Conn BI
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e204-e208. PubMed ID: 27743835
[TBL] [Abstract] [Full Text] [Related]
10. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract] [Full Text] [Related]
11. [Nuclear Medicine in diagnosis of breast cancer].
Iakovou IP; Giannoula E
Hell J Nucl Med; 2014; 17(3):221-7. PubMed ID: 25397630
[TBL] [Abstract] [Full Text] [Related]
12. Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.
Lehner J; Stötzer OJ; Fersching D; Nagel D; Holdenrieder S
Clin Chim Acta; 2013 Oct; 425():206-11. PubMed ID: 23916787
[TBL] [Abstract] [Full Text] [Related]
13. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and cea in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract] [Full Text] [Related]
14. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Stoetzer OJ; Fersching DM; Salat C; Steinkohl O; Gabka CJ; Hamann U; Braun M; Feller AM; Heinemann V; Siegele B; Nagel D; Holdenrieder S
Tumour Biol; 2013 Feb; 34(1):81-90. PubMed ID: 22983919
[TBL] [Abstract] [Full Text] [Related]
15. [Predictor of intrathoracic lymph node metastasis in peripheral non-small cell lung cancers 20 mm or less in greatest dimension].
Igai H; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Kyobu Geka; 2012 Mar; 65(3):175-83. PubMed ID: 22374590
[TBL] [Abstract] [Full Text] [Related]
16. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
Wallwiener CW; Wallwiener M; Kurth RR; Röhm C; Neubauer H; Banys MJ; Staebler A; Schönfisch B; Meuer SC; Giese T; Fehm TN
Breast Cancer Res Treat; 2011 Dec; 130(3):833-44. PubMed ID: 21858660
[TBL] [Abstract] [Full Text] [Related]
17. Kinetics of cea and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC).
Di Gioia D; Heinemann V; Nagel D; Untch M; Kahlert S; Bauerfeind I; Koehnke T; Stieber P
Tumour Biol; 2011 Aug; 32(4):777-85. PubMed ID: 21553235
[TBL] [Abstract] [Full Text] [Related]
18. breast cancer recurrence diagnosis suspected on tumor marker rising: value of whole-body 18FDG-PET/CT imaging and impact on patient management.
Champion L; Brain E; Giraudet AL; Le Stanc E; Wartski M; Edeline V; Madar O; Bellet D; Pecking A; Alberini JL
Cancer; 2011 Apr; 117(8):1621-9. PubMed ID: 21472709
[TBL] [Abstract] [Full Text] [Related]
19. breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum.
Deng B; Huang W; Tan QY; Fan XQ; Jiang YG; Liu L; Zhong YY; Liang YG; Wang RW
Mol Diagn Ther; 2011 Feb; 15(1):31-40. PubMed ID: 21469768
[TBL] [Abstract] [Full Text] [Related]
20. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study.
Fisher CS; Cole DJ; Mitas M; Garrett-Meyer E; Metcalf JS; Gillanders WE; Mikhitarian K; Urist MM; Mann GB; Doherty G; Herrmann VM; Hill AD; Eremin O; El-Sheemy M; Orr RK; Valle AA; Henderson MA; Dewitty RL; Sugg SL; Frykberg E; Yeh K; Bell RM; Baker MK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3():312-20. PubMed ID: 20853052
[TBL] [Abstract] [Full Text] [Related]
[Next]
